Adma Biologics (ADMA) Amortizatization of Intangibles (2011 - 2025)
Adma Biologics (ADMA) posted Amortizatization of Intangibles of $197000.0 for Q4 2025, up 15.88% on a QoQ basis from $170000.0 in Q3 2025, and down 10.05% year-over-year from $219000.0 in Q4 2024.
Adma Biologics (ADMA) Amortizatization of Intangibles (2011 - 2025) Analysis & Trends
Adma Biologics' Amortizatization of Intangibles history runs 13 years deep, the most recent figure standing at $197000.0 for Q4 2025.
- Quarterly Amortizatization of Intangibles fell 10.05% year-over-year to $197000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $717000.0 (down 24.61% YoY) and the FY2025 annual result came in at $717000.0, down 24.61% from the prior year.
- Amortizatization of Intangibles was $197000.0 for Q4 2025 at Adma Biologics, up from $170000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $981066.0 in Q3 2022 and bottomed at $160000.0 in Q2 2025.
- A 5-year average of $428050.0 and a median of $454075.5 in 2021 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles soared 101.87% — and 2024, when it plunged 68.62%.
- Adma Biologics' Amortizatization of Intangibles stood at $502858.0 in 2021, then slipped by 1.79% to $493873.0 in 2022, then surged by 41.33% to $698000.0 in 2023, then plunged by 68.62% to $219000.0 in 2024, then fell by 10.05% to $197000.0 in 2025.
- Business Quant data shows ADMA's Amortizatization of Intangibles at $197000.0 in Q4 2025, $170000.0 in Q3 2025, and $160000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | 197,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 197,000.00 |
| Dec 31, 2025 | 197,000.00 |
| Sep 30, 2025 | 170,000.00 |
| Sep 30, 2025 | 170,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Mar 31, 2025 | 190,000.00 |
| Mar 31, 2025 | 190,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Sep 30, 2024 | 252,000.00 |
| Sep 30, 2024 | 252,000.00 |
| Jun 30, 2024 | 227,000.00 |
| Jun 30, 2024 | 227,000.00 |
| Mar 31, 2024 | 253,000.00 |
| Mar 31, 2024 | 253,000.00 |
| Dec 31, 2023 | 698,000.00 |
| Dec 31, 2023 | 698,000.00 |
| Sep 30, 2023 | 721,000.00 |
| Sep 30, 2023 | 721,000.00 |